Genetics for targeting disease prevention: Diabetes

Primary Care - Clinics in Office Practice

Volumn 31, Issue 3, 2004, Pages 743-766

  Newell, Astrid M ^a  

^a OREGON DEPARTMENT OF HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

DIABETES MELLITUS; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FOOD INTAKE; GENE FUNCTION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; GENETIC RISK; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCREENING;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETES, GESTATIONAL; DISEASE PROGRESSION; ENVIRONMENT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; PREGNANCY; PRIMARY HEALTH CARE; RISK ASSESSMENT;

EID: 4344656566     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2004.04.002     Document Type: Review

References (130)

1. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics fact sheet: general information and national estimates on diabetes in the United States, 2003. 2003;US Department of Health and Human Services, National Institutes of Health, Bethesda (MD)
2. Boyle J., Honeycutt A., Narayan K., et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care. 24:2001;1936-1940
3. Engelau M., Narayan K., Saaddine J., Vinicor F. Addressing the burden of diabetes in the 21st century: better care and primary prevention. J Am Soc Nephrol. 14:(7 Suppl 2):2003;s88-s91
4. Cherry D., Burt C., Woodwell D. National ambulatory medical survey: 2001 summary. Adv Data. 337:2003;1-44
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 25:2002;S5-S20
6. Sipetic S., Vlajinac H., Kocev N., Marinkovic J., Radmanovic S., Denic L. Family history and risk of type 1 diabetes mellitus. Acta Diabetol. 39:2002;111-115
7. Altobelli E., Chiarelli F., Valenti M., Blasetti A., Di Orio F. Family history and risk of insulin-dependent diabetes mellitus: a population-based case control study. Acta Diabetol. 35:1998;57-60
8. Kimpimaki T., Kupila A., Hmalinen A., et al. The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study. J Clin Endocrinol Metab. 86:2001;4782-4788
9. American Diabetes Association. Prevention of type 1 diabetes mellitus (position statement). Diabetes Care. 26:2003;S140
10. Fagot-Campagna A. Emergence of type 2 diabetes mellitus in children: epidemiologic evidence. J Pediatr Metab. 13:(Suppl 6):2000;1395-1402
11. Bjornholt J.V., Erikssen G., Liestol K., Jervell J., Thaulow E., Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy non-diabetic men. Diabetes Care. 23:2000;1255-1259
12. Klein B., Klein R., Moss S., Cruickshanks K. Parental history of diabetes in a population-based study. Diabetes Care. 19:1996;827-830
13. Owen K., Ayres S., Corbett S., Hattersley A. Increased risk of diabetes in first-degree relatives of young-onset type 2 diabetic patients compared with relatives diagnosed later. Diabetes Care. 25:2002;636-637
14. Narayan K., Boyle J., Thompson T., Sorensen S., Williamson D. Lifetime risk for diabetes mellitus in the United States. JAMA. 290:2002;1884-1890
15. Benjamin S., Valdez R., Geiss L., Rolka D., Narayan K. Estimated number of adults with prediabetes in the US in 2000: opportunities for prevention. Diabetes Care. 26:2003;645-649
16. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention and metformin. N Engl J Med. 346:2002;393-403
17. American Diabetes Association. The prevention or delay of type 2 diabetes (position statement). Diabetes Care. 25:2002;742-749
18. Garcia Carrapato M. The offspring of gestational diabetes. J Perinat Med. 31:2003;5-11
19. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care. 21:(Suppl 2):1998;B9-B13
20. Van Assche F., Holemans K., Aerts L. Long-term consequences for offspring of diabetes during pregnancy. BMJ. 60:2001;173-182
21. Florez J., Hirschhorn J., Altschuler D. The inherited basis of diabetes mellitus: implications for the genetic analysis of complex traits. Annu Rev Genom Hum Genet. 4:2003;257-291
22. Dorman J., Bunker C. HLA DQ locus of the human leukocyte antigen complex and type 1 diabetes mellitus: a HuGE review. Epidemiol Rev. 22:2000;218-227
23. Bennett S., Todd J. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet. 30:1996;343-370
24. Stride A., Hattersley A. Different genes, different diabetes: lessons from maturity onset diabetes of the young. Ann Med. 34:2002;207-216
25. Winter M., Nakamura M., House D. Monogenic diabetes of youth; the MODY syndromes. Endocrinol Metab Clin North Am. 28:1999;765-785
26. Shepherd M., Ellis I., Ahmad A., et al. Predictive genetic testing in maturity-onset diabetes of the young (MODY). Diabet Med. 18:2001;417-421
27. Young C., Kumar S., Young M., Boulton A. Excess maternal history of diabetes in Caucasian and Afro-original non-insulin dependent diabetic patients suggests dominant maternal factors in disease transmission. Diabetes Res Clin Pract. 28:1995;47-49
28. Karter A., Rowell S., Ackerson L., et al. Excess maternal transmission of type 2 diabetes. The Northern California Kaiser Permanente Diabetes Registry. Diabetes Care. 22:1999;938-943
29. Mitchell B., Valdez R., Hazuda H., Haffner S., Monterrosa A., Stern M. Differences in the prevalence of diabetes and impaired glucose tolerance according to maternal or paternal history of diabetes. Diabetes Care. 16:1993;1262-1267
30. Lin R., Lee W., Lee Y., Chou P., Fu C. Maternal role in type 2 diabetes mellitus: indirect evidence for a mitochondrial inheritance. Int J Epidemiol. 23:1994;886-890
31. Poulton J., Luan J., Macaulay V., Hennings S., Mitchell J., Wareham N.J. Type 2 diabetes is associated with a common mitochondrial variant: evidence from a population-based case control study. Hum Mol Genet. 11:2002;1581-1583
32. Rocchi S., Auwerz J. Peroxisome proliferator-activated receptor gamma, the ultimate liaison between fat and transcription. Br J Nutr. 84:(Suppl 2):2000;S223-S227
33. Altshuler D., Hischhorn J., Klannemark M., et al. The common PPARgamma Pro12Ala polymorphism is associated with a decreased risk of type 2 diabetes. Nat Genet. 26:2000;76-80
34. Hara K., Okada T., Tobe K., et al. The Pro12Ala polymorphism in PPAR gamma 2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun. 271:2000;212-216
35. Baratta R., Di Paola R., Spampinato D., et al. Evidence for genetic epistasis in human insulin resistance: the combined effect of PC-1 (K121Q) and PPARgamma2 (P12A) polymorphisms. J Mol Med. 81:2003;718-723
36. Yang W., Hsiung C., Ho L., Chen Y., He C., Curb J. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia. 46:2003;977-983
37. Rangwala S., Rhoades B., Shapiro J., et al. Genetic modulation of PPARgamma phosphorylation regulates insulin sensitivity. Dev Cell. 5:2003;657-663
38. Tordjman J., Chauvet G., Questt J., Beale E., Forest C., Antoine B. Thiazolidinediones block fatty acid release by inducing glyceroneogenesis in fat cells. J Biol Chem. 278:2003;18785-18790
39. Hara K., Kubota N., Tobe K., et al. The role of PPARgamma as a thrifty gene both in mice and humans. Br J Nutr. 84:(Suppl 2):2000;S235-S239
40. Neel J. Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? Am J Hum Genet. 14:1962;353-362
41. Neel J., Weder A., Julius S. Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med. 42:1998;44-74
42. Batchelder T. The thrifty genotype revisited. Townsend Letter for Doctors and Patients 2000;180. Available at: www.mercola.com/2000/nov/19/genotype.htm. Accessed December 1, 2003.
43. Joffe B., Zimmet P. The thrifty genotype in type 2 diabetes: an unfinished symphony moving to its finale? Endocrine. 9:1998;139-141
44. Turner R., Levy J., Clark A. Complex genetics of type 2 diabetes: thrifty genes and previously neutral polymorphisms. QJM. 86:1993;413-417
45. Harder T., Franke K., Kolhoff R., Plagemann A. Maternal and paternal family history of diabetes in women with gestational diabetes or insulin-dependent diabetes mellitus type I. Gynecol Obstet Invest. 51:2001;160-164
46. Bowden D. Genetics of diabetes complications. Curr Diab Rep. 2:2002;191-200
47. Wang Y., Ng M., Lee S., et al. Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes. Diabetes Care. 26:2003;2410-2415
48. Bedlack R., Edelman D., Gibbs J., et al. APOE genotype is a risk factor for neuropathy severity in diabetic patients. Neurology. 60:2003;1022-1024
49. Pettersson-Fernholm K., Forsblom C., Hudson B., et al. The functional -374 T/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes. 52:2003;891-894
50. Birince A., Birinci H., Abidinoglu R., Durupinar B., Oge I. Diabetic retinopathy and HLA antigens in type 2 diabetes mellitus. Eur J Ophthalmol. 12:2002;89-93
51. Krolewski A.S., Fogarty D.G., Warram J.H. Hypertension and nephropathy in diabetes mellitus: what is inherited and what is acquired? Diabetes Res Clin Pract. 39:(Suppl):1998;S1-S14
52. Akerblom H.K., Vaarala O., Hyoty H., Ilonen J., Knip M. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet. 115:2002;18-29
53. Kostraba J., Cruickshanks K., Lawler-Heavner J., et al. Early exposure to cow's milk and solid foods in infancy, genetic predisposition, and risk of IDDM. Diabetes. 42:1993;288-295
54. Paronen J., Knip M., Savilahti E., et al. Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes. Finnish Trial to Reduce IDDM in the Genetically at Risk Study Group. Diabetes. 49:2000;1657-1665
55. Norris H., Barriga K., Klingensmith G., et al. Timing of initial cereal exposure in infancy and risk of islet cell autoimmunity. JAMA. 290:2003;1713-1720
56. Ziegler A., Schmid S., Huber D., Hummel M., Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA. 290:2003;1771-1772
57. Flodstrom M., Tsai D., Fien C., Maday A., Sarvetnick N. Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells. Diabetes. 52:2003;2025-2034
58. Sargeant L.A., Wareham N.J., Khaw K.T. Family history of diabetes identifies a group at increased risk for the metabolic consequences of obesity and physical inactivity in EPIC-Norfolk: a population based study (The European Prospective Investigation into Cancer). Int J Obes Relat Metabol Disord. 24:2000;1333-1339
59. National Institute of Diabetes and Digestive and Kidney Diseases. Weight Control Information Network: statistics related to overweight and obesity. 2003;US Department of Health and Human Services, National Institutes of Health, Bethesda (MD)
60. Goldfine A., Bouche C., Parker R., et al. Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A. 100:2003;2724-2729
61. Hanson R.L., Pettit D.J., Bennett P.H., et al. Familial relationships between obesity and NIDDM. Diabetes. 44:1995;418-422
62. Weijen D., Rich S., Meigs J., Krolewski A., Warram J. Risk of diabetes in siblings of index cases with type 2 diabetes: implications for genetic studies. Diabet Med. 19:2002;41-50
63. Ramachandran A., Snehalatha C., Satyavani K., Sivasankari S., Vijay V. Cosegregation of obesity with familial aggregation of type 2 diabetes mellitus. Diabetes Obes Metab. 2:2000;149-154
64. Rodriguez-Moran M., Guerrero-Romero F. Hyperinsulinemia and abdominal obesity are more prevalent in non-diabetic subjects with family history of type 2 diabetes. Arch Med Res. 31:2000;399-403
65. DePergola G., Pannacciulli N., Minenna A., Martina R., Cannito F., Giorgina R. Fuel metabolism in adult individuals with a wide range of body mass index: effect of a family history of type 2 diabetes. Diabetes Nutr Metab. 16:2003;41-47
66. ACE position statement on the insulin resistance syndrome. Endocr Pract. 9:2003;240-252
67. Groop L., Orho-Melander M. The dysmetabolic syndrome. J Intern Med. 250:2001;105-120
68. Unger R. Lipotoxic diseases. Annu Rev Med. 53:2002;319-336
69. Hirosumi J., Tuncman G., Chang L., et al. A central role for JNK in obesity and insulin resistance. Nature. 420:2002;333-336
70. Hsueh W., Cole S., Shuldiner A., et al. Interactions between variants in the beta 3 adrenergic receptor and peroxisome proliferator-activated receptor gamma2 genes and obesity. Diabetes Care. 24:2001;672-677
71. Carlsson S., Persson P.G., Alvarsson M., et al. Low birth weight, family history of diabetes, and glucose intolerance in Swedish middle-aged men. Diabetes Care. 22:1999;1043-1047
72. Hypponen E., Power C., Smith G.D. Prenatal growth, BMI, and risk of type 2 diabetes by early midlife. Diabetes Care. 26:2003;2512-2517
73. Segheri G., Anichini R., De Bellis A., Alviggi L., Franconi F., Breschi M.C. Relationship between gestational diabetes mellitus and low maternal birth weight. Diabetes Care. 25:2002;1761-1765
74. Hales C., Barker D. The thrifty phenotype hypothesis. Br Med Bull. 60:2001;5-20
75. Frayling T., Hattersley A. The role of genetic susceptibility in the association of low birth weight with type 2 diabetes. Br Med Bull. 60:2001;89-101
76. Sobngwi E., Boudou P., Mauvais-Jarvis F., et al. Effect of a diabetic environment in utero on predisposition to type 2 diabetes. Lancet. 361:2003;1861-1865
77. Knip M. Prediction and prevention of type 1 diabetes. Acta Paediar. 425:(Suppl):1998;54-62
78. Diabetes Prevention Trials - Type 1. Available at: http://www.niddk.nih. gov/patient/dpt_1/dpt_1.htm. Accessed December 1, 2003.
79. Type 1 Diabetes Trial Net. Available at: http://www.niddk.nih.gov/ patient/NIH2-TrialNet-Fact-Sheet.htm.
80. American Diabetes Association. Available at: http://www.diabetes.org/ homepage.jsp.
81. National Institute of Diabetes and Digestive and Kidney Diseases. Available at: http://www.niddk.nih.gov/. Accessed December 1, 2003.
82. Juvenile Diabetes Research Foundation. Available at: http://www.jdrf.org/ . Accessed December 1, 2003.
83. PANDA study. Available at: http://www.ufdiabetes.org/research_PANDA.asp. Accessed December 1, 2003.
84. Rewers M., Bugawan T., Norris J., et al. Newborn screening for HLA markers associated with IDDM: diabetes autoimmunity study of the young (DAISY). Diabetologia. 39:1996;807-812
85. Kupila A., Muona P., Simell T., et al. Feasibility of genetic and immunological prediction of type 1 diabetes in a population based birth cohort. Diabetologia. 44:2001;290-297
86. Berzina L., Shtauvere-Brameus A., Ludvigsson J., Sanjeevi C. Newborn screening for high risk human leukocyte antigen markers associated with insulin-dependent diabetes mellitus: the ABIS study. Ann N Y Acad Sci. 958:2002;312-316
87. Cinek O., Wilkinson E., Paltiel L., Saugstad O., Magnus P., Ronningen K. Screening for the IDDM high-risk genotype: a rapid microtitre plate method using serum as source of DNA. Tissue Antigens. 56:2000;344-349
88. Charatan F. High risk infants in Florida to be screened for type 1 diabetes. BMJ. 324:2002;188
89. Dahlquist G. Potentials and pitfalls in neonatal screening for type 1 diabetes. Acta Paediatr. 88:(Suppl):1999;80-82
90. Ross L. Minimizing risks: the ethics of predictive diabetes mellitus screening research in newborns. Arch Pediatr Adolesc Med. 157:2003;89-95
91. Schatz D., Gale E., Atkinson M. Why can't we prevent type 1 diabetes? May be it's time to try a different combination (commentary). Diabetes Care. 26:2003;3326-3328
92. Diabetes Prevention Trial - Type 1 Diabetes Study Group. Effects of insulin in relatives of patients with type 1 diabetes. N Engl J Med. 346:2002;1685-1691
93. Cockey C. Oral insulin doesn't prevent type 1 diabetes. AWHONN Lifelines. 7:2003;310-311
94. Herold K., Hagopian W., Auger J., et al. Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus. N Engl J Med. 346:2002;1692-1698
95. Efrat S. Preventing type 1 diabetes mellitus: the promise of gene therapy. Am J Pharmacogenet. 2:2002;129-134
96. Tuomilehto J., Lindstrom J., Eriksson J., et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 346:2002;393-403
97. Stange K., Zyzanski S., Jaen C., et al. Illuminating the "black box": a description of 4454 patient visits to 138 family physicians. J Fam Pract. 46:1998;377-389
98. Yoon P., Sheuner M., Peteron-Oehlke K., Gwinn M., Faucett A., Khoury M. Can family history be used as a tool for public health and preventive medicine? Genet Med. 4:2002;304-310
99. Harrison T., Hindorff L., Kim H., et al. Family history of diabetes as a potential public health tool. Am J Prev Med. 24:2003;152-159
100. Acheson L.S., Wiesner G.L., Zyzanski S.J., Goodwin M.A., Stange K.C. Family history taking in community family practice: implications for genetic screening. Genet Med. 2:2000;180-185
101. Scheuner M., Wang S.J., Raffel L.J., Larabell S., Rotter J. Family history: a comprehensive genetic risk assessment method for the chronic conditions of adulthood. Am J Med Genet. 71:1997;315-324
102. Williams R., Hunt S., Heiss G., et al. Usefulneess of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Health Study). Am J Cardiol. 87:2001;129-135
103. Pinsky L., Pagon R., Burke W. Genetics through a primary care lens. West J Med. 175:2001;47-50
104. Griffin S., Little P., Hales C., Kinmonth A., Wareham N. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev. 16:2000;164-171
105. Stern M., Williams K., Haffner S. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med. 136:2002;575-581
106. Lindstrom J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care. 26:2003;725-731
107. Park P., Griffin S., Sargeant L., Wareham N. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care. 25:2002;984-988
108. Herman W., Smith P., Thompson T., Engelgau M., Aubert R. A new and simple questionnaire to identify people at increased risk for undiagnosed diabetes. Diabetes Care. 18:1995;382-387
109. American Diabetes Association. Available at: http://www.diabetes.org/ info/risk/. Accessed December 1, 2003.
110. US Department of Health and Human Services. HHS launches new effort to reach people with diabetes who are undiagnosed (press release). 2003. Available at: www.hhs.gov/news/press/2003 pres/20031103a.html. Accessed December 1, 2003.
111. Gnanalingham M., Manns J. Patient awareness of genetic and environmental risk factors in non-insulin dependent diabetes mellitus: relevance to first-degree relatives. Diabet Med. 14:1997;660-662
112. Hu F., Li T., Colditz G., Willett W., Manson J. Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes in women. JAMA. 239:2003;1785-1791
113. Fisher E., Walker E., Bostrom A., Fischoff B., Haire-Joshu D., Johnson S.B. Behavioral science research in the prevention of diabetes: status and opportunities. Diabetes Care. 25:2002;599-606
114. Marteau T.M., Lerman C. Genetic risk and behavioural change. BMJ. 322:2001;1056-1059
115. Harwell T., Dettori N., Flook B., et al. Preventing type 2 diabetes: perceptions about risk and prevention in a population-based sample of adults ≥45 years of age. Diabetes Care. 24:2001;2007-2008
116. Pierce M., Harding D., Keen H., Bradley C. Risk and prevention of type II diabetes: offspring views. Br J Gen Pract. 51:2001;194-199
117. Forsyth L., Goetsch V. Perceived threat of illness and health protective behaviors in offspring of adults with non-insulin dependent diabetes mellitus. Behav Med. 23:1997;112-121
118. Bates B., Templeton A., Achter P., Harris T., Condit C. What does "a gene for heart disease" mean? A focus group study of public understandings of genetic risk factors. Am J Med Genet. 119A:2003;156-161
119. Wing R., Venditti E., Jakcic J., Polley B., Lang W. Lifestyle intervention in overweight individuals with a family history of diabetes. Diabetes Care. 21:1998;350-359
120. Polley B., Jakicic J., Venditti E., Barr S., Wing R. The effects of health beliefs on weight loss in individuals at high risk for NIDDM. Diabetes Care. 20:1997;1533-1538
121. US Preventive Services Task Force. Screening for type 2 diabetes in adults: recommendations and rationale. Am Fam Physician. 67:2003;2177-2180
122. Emilien G., Ponchon M., Caldas C., Isacson O., Maloteaux J.M. Impact of genomics on drug discovery and clinical medicine. QJM. 93:2000;391-423
123. Pearson E., Starkey B., Powell R., Gribble F., Clark P., Hattersley A. Genetic causes of hyperglycaemia and response to treatment in diabetes. Lancet. 362:2003;1275-1281
124. Boulot P., Chabbert-Buffet N., d'Ercole C., et al. French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes Care. 26:2003;2990-2993
125. Bartha J., Martinez-Del-Fresno P., Comino-Delgado R. Early diagnosis of gestational diabetes mellitus and prevention of diabetes-related complications. Eur J Obstet Gynecol Reprod Biol. 109:2003;41-44
126. US Preventive Services Task Force. Screening for gestational diabetes mellitus: recommendations and rationale. Obstet Gynecol. 101:2003;393-395
127. American Diabetes Association. Gestational diabetes mellitus (position statement). Diabetes Care. 25:(Suppl 1):2002;S94-S96
128. Langer O., Rodriguez D., Xenakis E., McFarland M., Berkus M., Arrendondo F. Intensified versus conventional management of gestational diabetes. Am J Obstet Gynecol. 170:1994;1036-1046
129. Linne Y., Barkeling B., Rossner S. Natural course of gestational diabetes mellitus: long term follow up of women in the SPAWN study. Br J Obstet Gynaecol. 109:(11):2002;1227-1231
130. Brenner S. Humanity as the model system. [editorial] Science. 302:2003;533